Order Article Reprints

Ikebe S, Koibuchi N, Shibata K, Sanada F, Shimizu H, Takenobu T, Taniyama Y. Experimental Study: The Development of a Novel Treatment for Chemotherapy-Resistant Tongue Cancer with the Inhibition of the Pathological Periostin Splicing Variant 1-2 with Exon 21. Cells. 2024; 13(16):1341. https://doi.org/10.3390/cells13161341

Ikebe, Shoji, Nobutaka Koibuchi, Kana Shibata, Fumihiro Sanada, Hideo Shimizu, Toshihiko Takenobu, and Yoshiaki Taniyama. 2024. "Experimental Study: The Development of a Novel Treatment for Chemotherapy-Resistant Tongue Cancer with the Inhibition of the Pathological Periostin Splicing Variant 1-2 with Exon 21" Cells 13, no. 16: 1341. https://doi.org/10.3390/cells13161341

Ikebe, S., Koibuchi, N., Shibata, K., Sanada, F., Shimizu, H., Takenobu, T., & Taniyama, Y. (2024). Experimental Study: The Development of a Novel Treatment for Chemotherapy-Resistant Tongue Cancer with the Inhibition of the Pathological Periostin Splicing Variant 1-2 with Exon 21. Cells, 13(16), 1341. https://doi.org/10.3390/cells13161341